Diabetic foot ulcer is a major complication of diabetes mellitus, and probably the major component of the diabetic foot. Diabetic foot ulcers are among one of the major global medical issues. Management of diabetic foot ulcers aims at fast healing and wound closure, by adopting a multidisciplinary therapeutic approach so as to avoid amputation.
The global Diabetic Foot Ulcers Treatment market is projected to reach US$ 5923.8 million in 2029, increasing from US$ 4651.8 million in 2022, with the CAGR of 3.4% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Diabetic Foot Ulcers Treatment market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Diabetic Foot Ulcers Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
3M Healthcare
Coloplast A/S
B.Braun Melsungen AG
Acelity L.P. Inc
Smith & Nephew Plc
Medtronic Plc
ConvaTec Inc
Mölnlycke Health Care
Organogenesis, Inc.
Derma Sciences Inc.
Sigvaris Inc.
Medline Industries, Inc
Cardinal Health Inc
MiMedx
URGO
Kerecis
Segment by Type
Wound Care Dressings (Foam dressings, Hydrocolloid Dressing, Hydrogel Dressing, Alginate Dressing, and Other Dressings)
Biologics (Growth factors, and Skin Graft and Skin Substitute)
Therapy Devices (Negative pressure wound devices, Hyperbaric Oxygen therapy devices, and Other Therapy Devices)
Segment by Application
Hospital
Clinics
Ambulatory Surgical Center
Homecare Setting
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Diabetic Foot Ulcers Treatment report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Diabetic Foot Ulcers Treatment Market Overview
1.1 Product Overview and Scope of Diabetic Foot Ulcers Treatment
1.2 Diabetic Foot Ulcers Treatment Segment by Type
1.2.1 Global Diabetic Foot Ulcers Treatment Market Value Comparison by Type (2023-2029)
1.2.2 Wound Care Dressings (Foam dressings, Hydrocolloid Dressing, Hydrogel Dressing, Alginate Dressing, and Other Dressings)
1.2.3 Biologics (Growth factors, and Skin Graft and Skin Substitute)
1.2.4 Therapy Devices (Negative pressure wound devices, Hyperbaric Oxygen therapy devices, and Other Therapy Devices)
1.3 Diabetic Foot Ulcers Treatment Segment by Application
1.3.1 Global Diabetic Foot Ulcers Treatment Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Ambulatory Surgical Center
1.3.5 Homecare Setting
1.4 Global Diabetic Foot Ulcers Treatment Market Size Estimates and Forecasts
1.4.1 Global Diabetic Foot Ulcers Treatment Revenue 2018-2029
1.4.2 Global Diabetic Foot Ulcers Treatment Sales 2018-2029
1.4.3 Global Diabetic Foot Ulcers Treatment Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Diabetic Foot Ulcers Treatment Market Competition by Manufacturers
2.1 Global Diabetic Foot Ulcers Treatment Sales Market Share by Manufacturers (2018-2023)
2.2 Global Diabetic Foot Ulcers Treatment Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Diabetic Foot Ulcers Treatment Average Price by Manufacturers (2018-2023)
2.4 Global Diabetic Foot Ulcers Treatment Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Diabetic Foot Ulcers Treatment, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Diabetic Foot Ulcers Treatment, Product Type & Application
2.7 Diabetic Foot Ulcers Treatment Market Competitive Situation and Trends
2.7.1 Diabetic Foot Ulcers Treatment Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Diabetic Foot Ulcers Treatment Players Market Share by Revenue
2.7.3 Global Diabetic Foot Ulcers Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Diabetic Foot Ulcers Treatment Retrospective Market Scenario by Region
3.1 Global Diabetic Foot Ulcers Treatment Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Diabetic Foot Ulcers Treatment Global Diabetic Foot Ulcers Treatment Sales by Region: 2018-2029
3.2.1 Global Diabetic Foot Ulcers Treatment Sales by Region: 2018-2023
3.2.2 Global Diabetic Foot Ulcers Treatment Sales by Region: 2024-2029
3.3 Global Diabetic Foot Ulcers Treatment Global Diabetic Foot Ulcers Treatment Revenue by Region: 2018-2029
3.3.1 Global Diabetic Foot Ulcers Treatment Revenue by Region: 2018-2023
3.3.2 Global Diabetic Foot Ulcers Treatment Revenue by Region: 2024-2029
3.4 North America Diabetic Foot Ulcers Treatment Market Facts & Figures by Country
3.4.1 North America Diabetic Foot Ulcers Treatment Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Diabetic Foot Ulcers Treatment Sales by Country (2018-2029)
3.4.3 North America Diabetic Foot Ulcers Treatment Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Diabetic Foot Ulcers Treatment Market Facts & Figures by Country
3.5.1 Europe Diabetic Foot Ulcers Treatment Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Diabetic Foot Ulcers Treatment Sales by Country (2018-2029)
3.5.3 Europe Diabetic Foot Ulcers Treatment Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Diabetic Foot Ulcers Treatment Market Facts & Figures by Country
3.6.1 Asia Pacific Diabetic Foot Ulcers Treatment Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Diabetic Foot Ulcers Treatment Sales by Country (2018-2029)
3.6.3 Asia Pacific Diabetic Foot Ulcers Treatment Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Diabetic Foot Ulcers Treatment Market Facts & Figures by Country
3.7.1 Latin America Diabetic Foot Ulcers Treatment Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Diabetic Foot Ulcers Treatment Sales by Country (2018-2029)
3.7.3 Latin America Diabetic Foot Ulcers Treatment Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Diabetic Foot Ulcers Treatment Market Facts & Figures by Country
3.8.1 Middle East and Africa Diabetic Foot Ulcers Treatment Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Diabetic Foot Ulcers Treatment Sales by Country (2018-2029)
3.8.3 Middle East and Africa Diabetic Foot Ulcers Treatment Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Diabetic Foot Ulcers Treatment Sales by Type (2018-2029)
4.1.1 Global Diabetic Foot Ulcers Treatment Sales by Type (2018-2023)
4.1.2 Global Diabetic Foot Ulcers Treatment Sales by Type (2024-2029)
4.1.3 Global Diabetic Foot Ulcers Treatment Sales Market Share by Type (2018-2029)
4.2 Global Diabetic Foot Ulcers Treatment Revenue by Type (2018-2029)
4.2.1 Global Diabetic Foot Ulcers Treatment Revenue by Type (2018-2023)
4.2.2 Global Diabetic Foot Ulcers Treatment Revenue by Type (2024-2029)
4.2.3 Global Diabetic Foot Ulcers Treatment Revenue Market Share by Type (2018-2029)
4.3 Global Diabetic Foot Ulcers Treatment Price by Type (2018-2029)
5 Segment by Application
5.1 Global Diabetic Foot Ulcers Treatment Sales by Application (2018-2029)
5.1.1 Global Diabetic Foot Ulcers Treatment Sales by Application (2018-2023)
5.1.2 Global Diabetic Foot Ulcers Treatment Sales by Application (2024-2029)
5.1.3 Global Diabetic Foot Ulcers Treatment Sales Market Share by Application (2018-2029)
5.2 Global Diabetic Foot Ulcers Treatment Revenue by Application (2018-2029)
5.2.1 Global Diabetic Foot Ulcers Treatment Revenue by Application (2018-2023)
5.2.2 Global Diabetic Foot Ulcers Treatment Revenue by Application (2024-2029)
5.2.3 Global Diabetic Foot Ulcers Treatment Revenue Market Share by Application (2018-2029)
5.3 Global Diabetic Foot Ulcers Treatment Price by Application (2018-2029)
6 Key Companies Profiled
6.1 3M Healthcare
6.1.1 3M Healthcare Corporation Information
6.1.2 3M Healthcare Description and Business Overview
6.1.3 3M Healthcare Diabetic Foot Ulcers Treatment Sales, Revenue and Gross Margin (2018-2023)
6.1.4 3M Healthcare Diabetic Foot Ulcers Treatment Product Portfolio
6.1.5 3M Healthcare Recent Developments/Updates
6.2 Coloplast A/S
6.2.1 Coloplast A/S Corporation Information
6.2.2 Coloplast A/S Description and Business Overview
6.2.3 Coloplast A/S Diabetic Foot Ulcers Treatment Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Coloplast A/S Diabetic Foot Ulcers Treatment Product Portfolio
6.2.5 Coloplast A/S Recent Developments/Updates
6.3 B.Braun Melsungen AG
6.3.1 B.Braun Melsungen AG Corporation Information
6.3.2 B.Braun Melsungen AG Description and Business Overview
6.3.3 B.Braun Melsungen AG Diabetic Foot Ulcers Treatment Sales, Revenue and Gross Margin (2018-2023)
6.3.4 B.Braun Melsungen AG Diabetic Foot Ulcers Treatment Product Portfolio
6.3.5 B.Braun Melsungen AG Recent Developments/Updates
6.4 Acelity L.P. Inc
6.4.1 Acelity L.P. Inc Corporation Information
6.4.2 Acelity L.P. Inc Description and Business Overview
6.4.3 Acelity L.P. Inc Diabetic Foot Ulcers Treatment Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Acelity L.P. Inc Diabetic Foot Ulcers Treatment Product Portfolio
6.4.5 Acelity L.P. Inc Recent Developments/Updates
6.5 Smith & Nephew Plc
6.5.1 Smith & Nephew Plc Corporation Information
6.5.2 Smith & Nephew Plc Description and Business Overview
6.5.3 Smith & Nephew Plc Diabetic Foot Ulcers Treatment Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Smith & Nephew Plc Diabetic Foot Ulcers Treatment Product Portfolio
6.5.5 Smith & Nephew Plc Recent Developments/Updates
6.6 Medtronic Plc
6.6.1 Medtronic Plc Corporation Information
6.6.2 Medtronic Plc Description and Business Overview
6.6.3 Medtronic Plc Diabetic Foot Ulcers Treatment Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Medtronic Plc Diabetic Foot Ulcers Treatment Product Portfolio
6.6.5 Medtronic Plc Recent Developments/Updates
6.7 ConvaTec Inc
6.6.1 ConvaTec Inc Corporation Information
6.6.2 ConvaTec Inc Description and Business Overview
6.6.3 ConvaTec Inc Diabetic Foot Ulcers Treatment Sales, Revenue and Gross Margin (2018-2023)
6.4.4 ConvaTec Inc Diabetic Foot Ulcers Treatment Product Portfolio
6.7.5 ConvaTec Inc Recent Developments/Updates
6.8 Mölnlycke Health Care
6.8.1 Mölnlycke Health Care Corporation Information
6.8.2 Mölnlycke Health Care Description and Business Overview
6.8.3 Mölnlycke Health Care Diabetic Foot Ulcers Treatment Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Mölnlycke Health Care Diabetic Foot Ulcers Treatment Product Portfolio
6.8.5 Mölnlycke Health Care Recent Developments/Updates
6.9 Organogenesis, Inc.
6.9.1 Organogenesis, Inc. Corporation Information
6.9.2 Organogenesis, Inc. Description and Business Overview
6.9.3 Organogenesis, Inc. Diabetic Foot Ulcers Treatment Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Organogenesis, Inc. Diabetic Foot Ulcers Treatment Product Portfolio
6.9.5 Organogenesis, Inc. Recent Developments/Updates
6.10 Derma Sciences Inc.
6.10.1 Derma Sciences Inc. Corporation Information
6.10.2 Derma Sciences Inc. Description and Business Overview
6.10.3 Derma Sciences Inc. Diabetic Foot Ulcers Treatment Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Derma Sciences Inc. Diabetic Foot Ulcers Treatment Product Portfolio
6.10.5 Derma Sciences Inc. Recent Developments/Updates
6.11 Sigvaris Inc.
6.11.1 Sigvaris Inc. Corporation Information
6.11.2 Sigvaris Inc. Diabetic Foot Ulcers Treatment Description and Business Overview
6.11.3 Sigvaris Inc. Diabetic Foot Ulcers Treatment Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Sigvaris Inc. Diabetic Foot Ulcers Treatment Product Portfolio
6.11.5 Sigvaris Inc. Recent Developments/Updates
6.12 Medline Industries, Inc
6.12.1 Medline Industries, Inc Corporation Information
6.12.2 Medline Industries, Inc Diabetic Foot Ulcers Treatment Description and Business Overview
6.12.3 Medline Industries, Inc Diabetic Foot Ulcers Treatment Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Medline Industries, Inc Diabetic Foot Ulcers Treatment Product Portfolio
6.12.5 Medline Industries, Inc Recent Developments/Updates
6.13 Cardinal Health Inc
6.13.1 Cardinal Health Inc Corporation Information
6.13.2 Cardinal Health Inc Diabetic Foot Ulcers Treatment Description and Business Overview
6.13.3 Cardinal Health Inc Diabetic Foot Ulcers Treatment Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Cardinal Health Inc Diabetic Foot Ulcers Treatment Product Portfolio
6.13.5 Cardinal Health Inc Recent Developments/Updates
6.14 MiMedx
6.14.1 MiMedx Corporation Information
6.14.2 MiMedx Diabetic Foot Ulcers Treatment Description and Business Overview
6.14.3 MiMedx Diabetic Foot Ulcers Treatment Sales, Revenue and Gross Margin (2018-2023)
6.14.4 MiMedx Diabetic Foot Ulcers Treatment Product Portfolio
6.14.5 MiMedx Recent Developments/Updates
6.15 URGO
6.15.1 URGO Corporation Information
6.15.2 URGO Diabetic Foot Ulcers Treatment Description and Business Overview
6.15.3 URGO Diabetic Foot Ulcers Treatment Sales, Revenue and Gross Margin (2018-2023)
6.15.4 URGO Diabetic Foot Ulcers Treatment Product Portfolio
6.15.5 URGO Recent Developments/Updates
6.16 Kerecis
6.16.1 Kerecis Corporation Information
6.16.2 Kerecis Diabetic Foot Ulcers Treatment Description and Business Overview
6.16.3 Kerecis Diabetic Foot Ulcers Treatment Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Kerecis Diabetic Foot Ulcers Treatment Product Portfolio
6.16.5 Kerecis Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Diabetic Foot Ulcers Treatment Industry Chain Analysis
7.2 Diabetic Foot Ulcers Treatment Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Diabetic Foot Ulcers Treatment Production Mode & Process
7.4 Diabetic Foot Ulcers Treatment Sales and Marketing
7.4.1 Diabetic Foot Ulcers Treatment Sales Channels
7.4.2 Diabetic Foot Ulcers Treatment Distributors
7.5 Diabetic Foot Ulcers Treatment Customers
8 Diabetic Foot Ulcers Treatment Market Dynamics
8.1 Diabetic Foot Ulcers Treatment Industry Trends
8.2 Diabetic Foot Ulcers Treatment Market Drivers
8.3 Diabetic Foot Ulcers Treatment Market Challenges
8.4 Diabetic Foot Ulcers Treatment Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
3M Healthcare
Coloplast A/S
B.Braun Melsungen AG
Acelity L.P. Inc
Smith & Nephew Plc
Medtronic Plc
ConvaTec Inc
Mölnlycke Health Care
Organogenesis, Inc.
Derma Sciences Inc.
Sigvaris Inc.
Medline Industries, Inc
Cardinal Health Inc
MiMedx
URGO
Kerecis
*If Applicable.